Clinical Trial Update: Apatinib for Metastatic Esophageal Cancer. [Phase 2]

View source ↗

Summary

This is a clinical trial update indicating that apatinib is being studied for metastatic esophageal cancer in Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Hangzhou Cancer Hospital | Conditions: Esophageal Cancer, Metastatic Esophageal Cancer | Phase 2 | Status: UNKNOWN